Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 2
1988 1
1989 1
1990 4
1991 5
1992 6
1993 5
1994 4
1995 8
1996 7
1997 8
1998 7
1999 7
2000 6
2001 10
2002 7
2003 9
2004 6
2005 6
2006 9
2007 5
2008 6
2009 7
2010 7
2011 3
2012 4
2013 7
2014 11
2015 7
2016 6
2017 9
2018 5
2019 8
2020 4
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Results by year

Filters applied: . Clear all
Page 1
European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management.
Brodszki N, Frazer-Abel A, Grumach AS, Kirschfink M, Litzman J, Perez E, Seppänen MRJ, Sullivan KE, Jolles S. Brodszki N, et al. Among authors: kirschfink m. J Clin Immunol. 2020 May;40(4):576-591. doi: 10.1007/s10875-020-00754-1. Epub 2020 Feb 17. J Clin Immunol. 2020. PMID: 32064578 Free PMC article.
Hereditary angioedema.
Sachse MM, Khachemoune A, Guldbakke KK, Kirschfink M. Sachse MM, et al. Among authors: kirschfink m. J Drugs Dermatol. 2006 Oct;5(9):848-52. J Drugs Dermatol. 2006. PMID: 17039649 Review.
Immunoblotting.
Kirschfink M, Terness P. Kirschfink M, et al. Methods Mol Med. 1998;13:361-71. doi: 10.1385/0-89603-485-2:361. Methods Mol Med. 1998. PMID: 21390855
Expanding Horizons in Complement Analysis and Quality Control.
Frazer-Abel A, Kirschfink M, Prohászka Z. Frazer-Abel A, et al. Among authors: kirschfink m. Front Immunol. 2021 Aug 9;12:697313. doi: 10.3389/fimmu.2021.697313. eCollection 2021. Front Immunol. 2021. PMID: 34434189 Free PMC article. Review.
Complement analysis in the era of targeted therapeutics.
Prohászka Z, Kirschfink M, Frazer-Abel A. Prohászka Z, et al. Among authors: kirschfink m. Mol Immunol. 2018 Oct;102:84-88. doi: 10.1016/j.molimm.2018.06.001. Epub 2018 Jun 20. Mol Immunol. 2018. PMID: 29933889 Review.
Modern complement analysis.
Kirschfink M, Mollnes TE. Kirschfink M, et al. Clin Diagn Lab Immunol. 2003 Nov;10(6):982-9. doi: 10.1128/cdli.10.6.982-989.2003. Clin Diagn Lab Immunol. 2003. PMID: 14607856 Free PMC article. Review. No abstract available.
Therapeutic complement inhibition: new developments.
Emlen W, Li W, Kirschfink M. Emlen W, et al. Among authors: kirschfink m. Semin Thromb Hemost. 2010 Sep;36(6):660-8. doi: 10.1055/s-0030-1262888. Epub 2010 Sep 23. Semin Thromb Hemost. 2010. PMID: 20865643 Review.
C1-inhibitor and transplantation.
Kirschfink M. Kirschfink M. Immunobiology. 2002 Sep;205(4-5):534-41. doi: 10.1078/0171-2985-00152. Immunobiology. 2002. PMID: 12396013 Review.
196 results